Anti-Mouse VEGFR2/CD309 Rabbit Recombinant Antibody
VEGFR2/CD309 Uni-rAbTM Recombinant Antibody for FC
Host / Isotype
Rabbit / IgG
Reactivity
mouse
Applications
FC
Conjugate
Unconjugated
CloneNo.
240214F12
Cat no : 98027-1-RR
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | bEnd.3 cells |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
The immunogen of 98027-1-RR is VEGFR2/CD309 Fusion Protein expressed in E. coli.
Tested Reactivity | mouse |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | Fusion Protein |
Full Name | kinase insert domain protein receptor |
Calculated Molecular Weight | 150KD |
GenBank Accession Number | NM_010612.2 |
Gene Symbol | VEGFR-2 |
Gene ID (NCBI) | 16542 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purfication |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Background Information
VEGFR2, also named as CD309, KDR and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for VEGFR2/CD309 antibody 98027-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |